| Asked and answered: Building a chatbot to address covid-19-related concerns M Herriman, E Meer, R Rosin, V Lee, V Washington, KG Volpp NEJM Catalyst Innovations in Care Delivery 1 (3), 2020 | 57 | 2020 |
| Does biologic therapy impact the development of PsA among patients with psoriasis? E Meer, JF Merola, R Fitzsimmons, TJ Love, S Wang, D Shin, Y Chen, ... Annals of the Rheumatic Diseases 81 (1), 80-86, 2022 | 37 | 2022 |
| Increased and biased deliberation in social anxiety LE Hunter, EA Meer, CM Gillan, M Hsu, ND Daw Nature Human Behaviour 6 (1), 146-154, 2022 | 30 | 2022 |
| Benchmarking accomplishments of leaders in American surgery and justification for enhancing diversity and inclusion PD Butler, CM Pugh, E Meer, E Lett, ED Tilahun, HA Sanfey, C Berry, ... Annals of surgery 272 (6), 897-903, 2020 | 29 | 2020 |
| Association of fenofibrate use and the risk of progression to vision-threatening diabetic retinopathy E Meer, JC Bavinger, Y Yu, BL VanderBeek JAMA ophthalmology 140 (5), 529-532, 2022 | 24 | 2022 |
| Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: a set of parallel case-control studies E Meer, T Thrastardottir, X Wang, M Dubreuil, Y Chen, JM Gelfand, ... The Journal of Rheumatology 49 (1), 53-59, 2022 | 23 | 2022 |
| Excessive deliberation in social anxiety LE Hunter, EA Meer, CM Gillan, M Hsu, ND Daw Nature human behaviour 6 (1), 146, 2022 | 13 | 2022 |
| Ocular conditions and injuries, detection and management in spaceflight E Meer, S Grob, EL Antonsen, A Sawyer npj Microgravity 9 (1), 37, 2023 | 11 | 2023 |
| Leber's hereditary optic neuropathy: Severe vascular pathology in a severe primary mutation S Asanad, E Meer, JJ Tian, M Fantini, M Nassisi, AA Sadun Intractable & rare diseases research 8 (1), 52-55, 2019 | 11 | 2019 |
| Time and distance cost of longer acting anti-VEGF therapies for macular degeneration: contributions to drug cost comparisons EA Meer, DH Oh, FL Brodie Clinical Ophthalmology (Auckland, NZ) 16, 4273, 2022 | 10 | 2022 |
| Association of mood disorders, substance abuse, and anxiety disorders in children and teens with serious structural eye diseases EA Meer, YH Lee, MX Repka, MF Borlik, FG Velez, C Perez, F Yu, ... American journal of ophthalmology 240, 135-142, 2022 | 9 | 2022 |
| LMX1B Locus Associated with Low-Risk Baseline Glaucomatous Features in the POAAGG Study E Meer, VL Qin, HV Gudiseva, B McGeehan, R Salowe, M Pistilli, J He, ... Genes 12 (8), 1252, 2021 | 8 | 2021 |
| Survival of iPSC-derived grafts within the striatum of immunodeficient mice: Importance of developmental stage of both transplant and host recipient CM Tom, S Younesi, E Meer, C Bresee, M Godoy, VB Mattis Experimental Neurology 297, 118-128, 2017 | 8 | 2017 |
| Leber's hereditary optic neuropathy: shifting our attention to the macula S Asanad, E Meer, M Fantini, E Borrelli, AA Sadun American Journal of Ophthalmology Case Reports 13, 13-15, 2019 | 7 | 2019 |
| A blueprint for increasing ethnic and racial diversity in US residency training programs PD Butler, JC Fowler, E Meer, IM Rosen, IM Reyes, JS Berns Academic Medicine 97 (11), 1632-1636, 2022 | 6 | 2022 |
| Design, implementation, and validation of an automated, algorithmic COVID-19 triage tool EA Meer, M Herriman, D Lam, A Parambath, R Rosin, KG Volpp, ... Applied Clinical Informatics 12 (05), 1021-1028, 2021 | 6 | 2021 |
| Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen T Thrastardottir, E Meer, A Hauksdottir, B Gudbjornsson, SY Kristinsson, ... Rheumatology 62 (2), 886-893, 2023 | 5 | 2023 |
| Google searches for thyroid eye disease after regulatory approval of teprotumumab JC Strawbridge, EA Meer, P Singh, DB Rootman JAMA ophthalmology 140 (6), 639-642, 2022 | 5 | 2022 |
| Self-identified black race as a risk factor for intraocular pressure elevation and iritis following prophylactic laser peripheral iridotomy MO Adetunji, E Meer, G Whitehead, P Hua, A Badami, V Addis, T Gorry, ... Journal of Glaucoma 31 (4), 218-223, 2022 | 5 | 2022 |
| Vindell Washington, and Kevin G. Volpp.“Asked and Answered: Building a Chatbot to Address Covid-19-Related Concerns.” M Herriman, E Meer, R Rosin, V Lee NEJM Catalyst, https://catalyst. nejm. org/doi/full/10.1056/cat 20, 2020 | 5 | 2020 |
